An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, ...

Millions of people worldwide are likely to lose access to anti HIV drugs, and thousands more people could die, after the US ...

The Conference for Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

Utilizing syringe service programs to provide comprehensive PrEP care shows promise for encouraging more people who inject ...

Camp Dreamcatcher launched at the height of ‘90s stigma around HIV, has served thousands of children living with or affected ...

The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...

This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising ...

Pamela Bjorkman of the California Institute of Technology won the prize for ‘offering new hope in the fight against ...